Koninklijke Philips | PHG - Operating Expenses


Koninklijke Philips reported EUR3.66B in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Abbott USD 11.66B 1.2B Sep/2026
Baxter International USD 6.5B 3.82B Sep/2026
Becton, Dickinson and Co. USD 24.42B 283M Jun/2026
Boston Scientific USD 4.13B 72M Sep/2026
Danaher USD 53.62B 1.04B Sep/2026
Demant DKK 10.79B 1.16B Jun/2026
Dexcom USD 990.1M 53.5M Jun/2026
Edwards Lifesciences USD 1.22B 87.6M Jun/2026
Fresenius EUR 5.23B 9M Jun/2026
General Electric Aerospace USD 17.52B 118M Sep/2026
Getinge SEK 7.03B 2.96B Jun/2026
Globus Medical USD 835.58M 239.73M Jun/2026
GN Store Nord DKK 2.11B 51M Jun/2026
Hitachi JPY 2.56T 140.17B Sep/2026
Idexx Laboratories USD 791.02M 12.78M Jun/2026
Insulet USD 672M 32.3M Jun/2026
Integra LifeSciences USD 368.53M 674.84M Sep/2026
Intuitive Surgical USD 2B 86.5M Sep/2026
J&J USD 18.93B 1.09B Sep/2026
Koninklijke Philips EUR 3.66B 1.43B Mar/2026
Medtronic USD 7.92B 203M Jun/2026
Philips EUR 3.75B 147M Jun/2026
ResMed USD 1.01B 83.57M Jun/2026
Smith & Nephew USD 2.59B 71M Jun/2026
Steris USD 1.21B 62.8M Jun/2026
Stryker USD 4.8B 118M Jun/2026
Teleflex USD 2.9B 179.9M Jun/2026
Terumo JPY 222.33B 46.54B Jun/2026
Zimmer Biomet Holdings USD 1.83B 140.7M Jun/2026